Oncology and Hematology
Episodes 17-32 of 53
Ghayas Issa, MD
Amir Fathi, MD
- MinuteCE®
Incorporating Guideline-Recommended Targeted Therapies Into R/R AML Management
1.00 program creditGhayas Issa, MD
Amir Fathi, MD
Ghayas Issa, MD
Amir Fathi, MD
Ghayas Issa, MD
Amir Fathi, MD
- CME/CE Broadcast Replay
Pulmonary Hypertension: Getting the Right Diagnosis and Knowing When to Refer
1.00 creditVallerie V. McLaughlin, MD
Marsha Burks, BSN, RN
Rajan Saggar, MD
- MinuteCE®
Tailoring First-Line Regimens: Patient-Centric Selection in Metastatic ESCC
0.75 program creditsHarry Yoon, MD
Jaffer Ajani, MD
Jaffer Ajani, MD
Harry Yoon, MD
Jaffer Ajani, MD
- MinuteCE®
Strategies for Navigating First-Line Treatment Selection in Metastatic ESCC
0.75 program creditsHarry Yoon, MD
Jaffer Ajani, MD
- MinuteCE®
Effective Monitoring and Management of Adverse Effects in Metastatic ESCC
0.75 program creditsHarry Yoon, MD
Jaffer Ajani, MD
Harry Yoon, MD
Jaffer Ajani, MD
Harry Yoon, MD
Jaffer Ajani, MD
- MinuteCE®
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
0.75 program creditsHarry Yoon, MD
Daniel P. Petrylak, MD
Elizabeth R. Plimack, MD, MS, FASCO
Evan Y. Yu, MD
Nathan A. Boggs, MD
Tracy George, MD
Lindsay Rein, MD
Nathan A. Boggs, MD
Tracy George, MD
Lindsay Rein, MD
